Ami Simunovich
Public Communications Contact presso BECTON, DICKINSON AND COMPANY
Profilo
Ami E.
Simunovich is currently the Director at Medical Device Innovation Consortium and the Chief Quality & Regulatory Officer, Executive VP at Becton, Dickinson & Co. They are also a Trustee at Fairleigh Dickinson University.
Previously, they worked as an Associate General Counsel at C.
R.
Bard, Inc. (New Jersey) and as a Principal at Catalent, Inc. Dr. Simunovich holds a doctorate degree from Seton Hall University School of Law and Ernest Mario School of Pharmacy.
Posizioni attive di Ami Simunovich
| Società | Posizione | Inizio |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Public Communications Contact | - |
Medical Device Innovation Consortium
 Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Medical Device Innovation Consortium (MDIC) is a collective endeavor focused on realizing the potential of transformative innovation in the medical device industry. The private company is based in St. Louis Park, MN. The company encourages med device companies to adopt advanced technologies such as AI, ML, and IoT to develop supply resiliency, production agility, innovation rigor, and secure medical product supply. MDIC's CFQ program is a dynamic collaborative exchange and engagement of diverse experiences and professional insights in advancing innovation to the forefront of patient safety and accessibility. The company was founded by William A. Hawkins. Andrew Fish has been the CEO of the company since 2022. | Director/Board Member | - |
| Fairleigh Dickinson University | Director/Board Member | - |
Precedenti posizioni note di Ami Simunovich
| Società | Posizione | Fine |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | - |
| C.R. BARD | Corporate Officer/Principal | - |
Formazione di Ami Simunovich
| Seton Hall University School of Law | Doctorate Degree |
| Ernest Mario School of Pharmacy | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| CATALENT, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Medical Device Innovation Consortium (MDIC) is a collective endeavor focused on realizing the potential of transformative innovation in the medical device industry. The private company is based in St. Louis Park, MN. The company encourages med device companies to adopt advanced technologies such as AI, ML, and IoT to develop supply resiliency, production agility, innovation rigor, and secure medical product supply. MDIC's CFQ program is a dynamic collaborative exchange and engagement of diverse experiences and professional insights in advancing innovation to the forefront of patient safety and accessibility. The company was founded by William A. Hawkins. Andrew Fish has been the CEO of the company since 2022. | Commercial Services |
- Borsa valori
- Insiders
- Ami Simunovich
